TNFRSF9 and neoplasm: Although the trimeric protein had short in vivo stability, the anti-tumor response generated in mouse tumor models was similar to an agonistic anti-4-1BB mAb and the trimer did not induce toxicity, which was apparent with the agonistic mAb.